Gremubamab
Based on 1 publication(s) in Google Scholar
Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98.40%
- CAS. Nr.: 1800381-36-5
- Molecular Weight:200.46 kDa
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Gremubamab
More
Biologische Aktivität
Beschreibung
Isotype
[VH-CH1-scFv-VH-VK-h-CH2-CH3_L-kappa]2
Recommend Isotype Controls
Species Reactivity
Pseudomonas aeruginosa
IC50 & Target
PcrV & PslG
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Rabbits (acute pneumonia model)[2]
-
Dosage:1, 5, 15 mg/kg
-
Administration:I.v.; at 1 h postinfection
-
Result:Improved survival outcomes in a dose-dependent manner in a rabbit acute pneumonia model.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
[VH-CH1-scFv-VH-VK-h-CH2-CH3_L-kappa]2
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Pseudomonas aeruginosa can bind Gremubamab. The EC50 for this effect is 136.6 ng/mL.
Chemical Information
-
CAS. Nr. 1800381-36-5
-
Appearance Liquid
-
Molecular Weight 200.46 kDa
-
Color Colorless to light yellow
-
SMILES
[Gremubamab]
-
Synonyms
MEDI3902
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Antimicrob Agents Chemother
XAB06, a glyco-humanized broad-spectrum anti- Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model. [Abstract]2026 Sep 3:e0027726. PMID: 42690181
Reinheit & Dokumentation
-
Data Sheet (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
[1]. Chastre J, et al. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial. Crit Care. 2022 Nov 15;26(1):355. [Content Brief]
[2]. Le HN, et al. Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models. Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00710-19. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Gremubamab Related Classifications
HY-P99649 Related Classifications
Powered by Bioz